Andrew Astor Power - 05 Mar 2022 Form 4 Insider Report for NEPHROS INC (NEPH)

Reporting relationship: President, CEO & CFO, Director
Issuer ticker: NEPH
Reported as of: 05 Mar 2022
Net transaction value: +$40,000
SEC form: 4
Accepted by SEC: 07 Mar 2022, 16:44:41 UTC
Prior SEC filing: 16 Dec 2021
Source filing: View source filing
Reporting owner signature: /s/ Christopher Melsha as attorney-in-fact for Andrew Astor pursuant to Power of Attorney previously filed.

Key filing fact

Andrew Astor Power filed Form 4 for NEPHROS INC (NEPH) on 07 Mar 2022.

Key facts

This page summarizes Andrew Astor Power's Form 4 filing for NEPHROS INC (NEPH).
2 reported transactions and 8 derivative rows are listed below.
Accepted by SEC: 07 Mar 2022, 16:44.

Change

Previous filing in this sequence was filed on 16 Dec 2021.
Current net transaction value: +$40,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NEPH transaction

Common Stock

Options Exercise

Transaction value: $40,000
Shares: +14,815
Change %: +19%
Price: $2.70
Shares after: 92,773
Date: 05 Mar 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NEPH transaction Derivative

Warrants (right to buy)

Options Exercise

Transaction value: $0
Shares: -14,815
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 05 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 14,815
Exercise price: $2.70

NEPH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 64,399
Date: 05 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 64,399
Exercise price: $4.14
Footnotes: F1

NEPH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 46,525
Date: 05 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 46,525
Exercise price: $2.64
Footnotes: F2

NEPH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,556
Date: 05 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,556
Exercise price: $4.50
Footnotes: F3

NEPH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 22,223
Date: 05 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 22,223
Exercise price: $5.85
Footnotes: F4

NEPH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 20,000
Date: 05 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,000
Exercise price: $8.30
Footnotes: F5

NEPH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 152,064
Date: 05 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 152,064
Exercise price: $7.07
Footnotes: F6

NEPH holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 38,612
Date: 05 Mar 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 38,612
Exercise price: $6.82
Footnotes: F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

On 2/13/17, the Reporting Person was granted an option to purchase 64,399 shares of common stock of the Company. Options to purchase 8,049 shares vested on 2/13/18; options to purchase 24,150 shares vest quarterly in 12 equal amounts commencing on 5/13/18; and options to purchase 32,200 shares vested upon achievement of previously disclosed performance measures.

Footnote F2

On 5/1/17, the Reporting Person was granted an option to purchase 46,525 shares of common stock of the Company. Options to purchase 5,815 shares vested on 5/1/18; options to purchase 17,447 shares vest quarterly in 12 equal amounts commencing on 7/1/18; and options to purchase 23,263 shares vested upon achievement of previously disclosed performance measures.

Footnote F3

100% vested.

Footnote F4

On 12/19/18, the Reporting Person was granted an option to purchase 22,223 shares of common stock of the Company. Options to purchase 5,555 shares vested on 12/19/19 and options to purchase 16,668 shares vest quarterly in 12 equal amounts commencing on 3/19/20.

Footnote F5

On 12/16/19, the Reporting Person was granted an option to purchase 20,000 shares of common stock of the Company. Options to purchase 5,000 shares vest on 12/16/20 and options to purchase 15,000 shares vest quarterly in 12 equal amounts commencing on 3/16/21.

Footnote F6

On 8/24/20, the Reporting Person was granted an option to purchase 152,064 shares of common stock of the Company. Options to purchase 38,016 shares vest on 8/24/21 and options to purchase 114,048 shares vest quarterly in 12 equal amounts commencing on 11/24/21.

Footnote F7

On 12/14/21, the Reporting Person was granted an option to purchase 38,612 shares of common stock of the Company. Options to purchase 9,653 shares vest on 12/14/22 and options to purchase 28,959 shares vest quarterly in 12 equal amounts commencing on 3/14/23.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .